Translating Scientific Advances In Inner Ear Biology Into Novel Therapies For People With Hearing Disorders


Decibel Therapeutics is a hearing company focused on discovering and developing new therapies to protect, repair and restore hearing. By combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, Decibel is pioneering a comprehensive approach to define the underlying biological causes of hearing loss and develop a pipeline of breakthrough therapies targeted to specific indications and populations. 


Year Invested: 2015
Location: Cambridge, Mass.
Visit: www.decibeltx.com

Recent News

February 6, 2019
Decibel Therapeutics to Present at the Association for Research in Otolaryngology (ARO) Conference

February 5, 2019
Decibel Therapeutics Bolsters Leadership Team with Appointments of Chief Medical Officer and Chief Operating Officer

January 7, 2019
Decibel Therapeutics and Cocoon Biotech Announce Collaboration to Develop Proprietary Formulations for Delivery of Medicines to the Inner Ear

Read More News

Associated Team Members

Kevin Starr
Partner

Craig Muir
Partner/Chief Technology Officer